Regcon Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REGCON HOLDINGS
REGCON HOLDINGS has forty-seven approved drugs.
Summary for Regcon Holdings
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 42 |
| NDAs: | 47 |
Drugs and US Patents for Regcon Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regcon Holdings | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 207428-002 | Oct 21, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | LACOSAMIDE | lacosamide | SOLUTION;ORAL | 220386-001 | Jan 29, 2026 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | ALLOPURINOL | allopurinol | TABLET;ORAL | 204467-003 | May 22, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET;ORAL | 215466-001 | May 27, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
